Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Eric M Granowicz & Brian A Jonas. (2022) Targeting TP53-Mutated Acute Myeloid Leukemia: Research and Clinical Developments. OncoTargets and Therapy 15, pages 423-436.
Read now
Read now
Panagiota Papanagnou, Theodora Stivarou, Ioannis Papageorgiou, Georgios E Papadopoulos & Anastasios Pappas. (2017) Marketed drugs used for the management of hypercholesterolemia as anticancer armament. OncoTargets and Therapy 10, pages 4393-4411.
Read now
Read now
Articles from other publishers (18)
Amber Afzal, Mark A. Fiala, Meagan A. Jacoby & Matthew J. Walter. (2023) Statin use in myelodysplastic syndromes is associated with a better survival and decreased progression to leukemia. Blood Advances 7:15, pages 3838-3841.
Crossref
Crossref
Daniel Tuyet Kristensen, Andreas Kisbye Øvlisen, Lasse Hjort Kyneb Jakobsen, Marianne Tang Severinsen, Louise Hur Hannig, Jørn Starklint, Morten Hagemann Hilsøe, Anders Pommer Vallentin, Mette Brabrand, Hans Carl Hasselbalch, Tarec Christoffer El-Galaly & Anne Stidsholt Roug. (2023) Use of statins and risk of myeloproliferative neoplasms: a Danish nationwide case-control study. Blood Advances 7:14, pages 3450-3457.
Crossref
Crossref
Beniamin Oskar Grabarek, Dariusz Boroń, Emilia Morawiec, Piotr Michalski, Veronica Palazzo-Michalska, Łukasz Pach, Barbara Dziuk, Magdalena Świder & Nikola Zmarzły. (2021) Crosstalk between Statins and Cancer Prevention and Therapy: An Update. Pharmaceuticals 14:12, pages 1220.
Crossref
Crossref
Kenichi Miyamoto & Yosuke Minami. (2020) Cutting Edge Molecular Therapy for Acute Myeloid Leukemia. International Journal of Molecular Sciences 21:14, pages 5114.
Crossref
Crossref
Cosimo Cumbo, Giuseppina Tota, Luisa Anelli, Antonella Zagaria, Giorgina Specchia & Francesco Albano. (2020) TP53 in Myelodysplastic Syndromes: Recent Biological and Clinical Findings. International Journal of Molecular Sciences 21:10, pages 3432.
Crossref
Crossref
Anthony M. Hunter & David A. Sallman. (2020) Targeting TP53 Mutations in Myelodysplastic Syndromes. Hematology/Oncology Clinics of North America 34:2, pages 421-440.
Crossref
Crossref
Süreyya Ölgen. 2020. Drug Repurposing in Cancer Therapy. Drug Repurposing in Cancer Therapy
395
437
.
Jiryeon Jang, Jeeyun Lee, Jun Ho Jang, Chul Won Jung & Silvia Park. (2019) Anti-leukemic effects of simvastatin on NRASG12D mutant acute myeloid leukemia cells. Molecular Biology Reports 46:6, pages 5859-5866.
Crossref
Crossref
Sureyya Olgen & Lakshmi P. Kotra. (2019) Drug Repurposing in the Development of Anticancer Agents. Current Medicinal Chemistry 26:28, pages 5410-5427.
Crossref
Crossref
Anthony M. Hunter & David A. Sallman. (2019) Current status and new treatment approaches in TP53 mutated AML. Best Practice & Research Clinical Haematology 32:2, pages 134-144.
Crossref
Crossref
N.F. Zolkiflee, M.M.R. Meor Mohd Affandi & A.B.A. Majeed. (2019) Molecular dynamics and related solution chemistry of lovastatin in aqueous solution of arginine: Viscometric analysis. Journal of Molecular Liquids 279, pages 386-391.
Crossref
Crossref
Renjitha Gopurappilly, Bipan Kumar Deb, Pragnya Chakraborty & Gaiti Hasan. (2018) Stable STIM1 Knockdown in Self-Renewing Human Neural Precursors Promotes Premature Neural Differentiation. Frontiers in Molecular Neuroscience 11.
Crossref
Crossref
Andrew KuykendallNicolas DuployezNicolas BoisselJeffrey E. LancetJohn S. Welch. (2018) Acute Myeloid Leukemia: The Good, the Bad, and the Ugly. American Society of Clinical Oncology Educational Book:38, pages 555-573.
Crossref
Crossref
Tatiana Y. Hargrove, Laura Friggeri, Zdzislaw Wawrzak, Suneethi Sivakumaran, Eugenia M. Yazlovitskaya, Scott W. Hiebert, F. Peter Guengerich, Michael R. Waterman & Galina I. Lepesheva. (2016) Human sterol 14α-demethylase as a target for anticancer chemotherapy: towards structure-aided drug design. Journal of Lipid Research 57:8, pages 1552-1563.
Crossref
Crossref
Alexandre Parks & François Marceau. (2016) Lysosomotropic cationic drugs induce cytostatic and cytotoxic effects: Role of liposolubility and autophagic flux and antagonism by cholesterol ablation. Toxicology and Applied Pharmacology 305, pages 55-65.
Crossref
Crossref
Cecilia Sheen, Tiffaney Vincent, David Barrett, Edwin M. Horwitz, Jessica Hulitt, Eliza Strong, Stephan A. Grupp & David T. Teachey. (2011) Statins are active in acute lymphoblastic leukaemia (ALL): a therapy that may treat ALL and prevent avascular necrosis. British Journal of Haematology 155:3, pages 403-407.
Crossref
Crossref
Antonio Rodriguez-Ariza, Chary Lopez-Pedrera, Enrique Aranda & Nuria Barbarroja. (2011) VEGF targeted therapy in acute myeloid leukemia. Critical Reviews in Oncology/Hematology 80:2, pages 241-256.
Crossref
Crossref
Guillermo Hermo, Hernán Farina, Daniel Alonso & Daniel Gomez. (2011) Effect of atorvastatin in a case of feline multicentric lymphoma — Case report. Acta Veterinaria Hungarica 59:1, pages 69-76.
Crossref
Crossref